Veea launches VigiLynx service for Telcel customers in Mexico

Veea Inc. (NASDAQ: VEEA) announced the commercial availability of VigiLynx, an edge intelligence and automation platform for business locations, according to a company press release dated July 21, 2026.

For a limited time, eligible new and existing Telcel Internet Gestionado customers in Mexico can receive VigiLynx at no charge for the duration of their contract by downloading the AIoT and VeeaVision apps within SecureConnect products. The service is also available through Veea's distributors and channel partners globally.

VigiLynx is described as a single compact device combining cybersecurity, video surveillance, IoT connectivity, and edge AI compute. The platform integrates functions that would otherwise require separate hardware, including a router, SD-WAN, Wi-Fi access point, IoT gateway, next-generation firewall, and network video recorder. Compatible cameras and sensors can be added separately, and optional Edge AI compute is available as an add-on.

The platform operates across three functional layers. The first covers secure networking and cybersecurity under the SecureConnect brand. The second, VeeaVision and AIoT, handles video and sensor monitoring. The third provides optional Edge AI capabilities through Veea's VeeaONE platform, supporting inferencing on NVIDIA Jetson, x86, or Linux-based systems.

The system is managed remotely through Veea's VeeaCloud service or a smartphone app, and is designed to continue operating locally if internet connectivity is interrupted.

"With VigiLynx, an SMB gets what until now only large enterprises could afford: a cybersecure, intelligent business location that senses, learns, and acts on its own data — without an IT department," said Allen Salmasi, chairman and CEO of Veea.

Veea, founded in 2014 and headquartered in New York City, holds more than 123 patents in related technology domains.

You May Also Be Interested In

• Qualcomm Tells Customers Prices Going Up Double-digit Percent - Bloomberg
• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Scribe Therapeutics indicating open above $29, IPO priced at $15